Generics 23

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Nilotinib manufacturers

23 products found

Filters

nilotinib

Capsules 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15017
A pharmaceutical manufacturer based in the EU that has been active for 20+ years. The main therapeutic areas include oncology. The company's production lines are GMP-compliant.

Manufacturer usually replies in 5 days

nilotinib

Capsules 150mg, 200mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Distribution only
Manufacturer #1250
This pharmaceutical company is a leading player in the Baltic States with a global reach, focusing on the development and production of a wide range of pharmaceutical products. Their portfolio includes prescription medications, over-the-counter drugs, and active pharmaceutical ingredients (APIs). They have a strong presence in key regions like the EU and North America, with production lines dedicated to various therapeutic areas including heart health, diabetes, central nervous system disorders, and oncology. The company emphasizes quality assurance through GMP certifications and holds several product patents.

Manufacturer usually replies in 4 days

nilotinib

Capsules 50 mg, 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Germany , Gibraltar , Greece , Hungary , Iceland , Ireland , Italy , Isle Of Man , Jersey , Kosovo , Latvia , Liechtenstein , Lithuania , Luxembourg , North Macedonia , Malta , Montenegro , Moldova , Monaco , Netherlands , Norway , Poland , Portugal , Serbia , San Marino , Slovakia , Slovenia , Spain , Svalbard And Jan Mayen , Sweden , Switzerland , Ukraine , United Kingdom , Vatican , Vietnam
Available for
Licensing with supply
Comments
Indication: Antibiotic; Status: Under Development Q1 2024
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 10 days

Want to see all 23 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the drug Nilotinib?

Nilotinib is a selective tyrosine kinase inhibitor. Nilotinib is medication to treat blood cancer and, more precisely, patients with Philadelphia chromosome-positive chronic myelogenous leukemia. The nilotinib drug is usually used when other treatments have failed; it is to overcome Imatinib when patients are resistant to this drug. Nilotinib is a second-generation tyrosine kinase inhibitor. Due to its rare use, Nilotinib is considered an “orphan medicine.”
Nilotinib medication was approved in 2007 by the FDA and in 2009 by the EU EMA. Nilotinib is on the list of the World Health Organization’s essential medicines.

Nilotinib wholesalers and manufacturers:

Novartis manufactures Nilotinib under the name Tasigna. Novartis is also the marketing authorization holder.
Nilotinib suppliers market it in the form of oral capsules. Nilotinib can be found in capsules of 50 mg, 100 mg, and 200 mg.

Nilotinib for sales:

The retail prices of Nilotinib depend on the dosage of the capsule. In the US, for a 50 mg capsule, Nilotinib costs around $ 137 per unit, it equals to $ 16,470 for 120 capsules. For 150 mg and 200 mg, one Nilotinib capsule costs $ 137, and for 28 capsules, it costs $ 3,850.
Nilotinib is mostly available from the European Union, India, and the United States on the Pipelinepharma B2B marketplace. If you are looking for Nilotinib manufacturers, our online platform will help Nilotinib distributors to connect globally with qualified manufacturers that have been verified through quality control procedures. On Pipelinepharma website, you can find a list of many pharmaceutical products, including Nilotinib. Thanks to our very intuitive website, you can easily place an order for Nilotinib and be in relation with Nilotinib manufacturers.

How to use Nilotinib drug?

Depending on the phase the patient is in, the Nilotinib dosage will be adjusted. For a newly diagnosed patient, the usual dose for an adult is 300 mg taken twice a day. For a resistant patient, the prescription for an adult is 400 mg taken twice a day. In both cases, Nilotinib drugs must be taken orally within 12 hours in between the two doses. It is better to take Nilotinib medication on an empty stomach; it means no food 2 hours before taking the drug and 1 hour after taking it.
Nilotinib medication can have some side effects; the most common ones are nausea, rash, headache, and fatigue. Patients should not take Nilotinib if they are allergic if they have low blood levels of potassium or magnesium or a heart rhythm disorder called long QT syndrome.
It must be stored at room temperature, away from heat, moisture, and direct light.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation